Iguratimod is used to treat Ulcerative colitis, Crohn’s disease, systemic lupus erythematosus, Wilson’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis and type 2 diabetes mellitus. Iguratimod is a disease-modifying anti-rheumatic drug (DMARD). Its therapeutic use is listed as anti-inflammatories. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Careram, Kolbet and Iremod. Its PubChem CID is 124246.
Iguratimod
| CAS No | 123663-49-0 |
|---|---|
| Molecular Formula | C17H14N2O6S |
| Molecular Weight | 374.4 g/mol |
| Synonyms | N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Iguratimod is used to treat Ulcerative colitis, Crohn's disease, systemic lupus erythematosus, Wilson's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis and type 2 diabetes mellitus.
The listed CAS number is 123663-49-0.
The listed molecular formula is C17H14N2O6S.
The listed molecular weight is 374.4 g/mol.
N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide.
The source lists Careram, Kolbet and Iremod.